Osteomyelitis: Infection of the Bone
Osteomyelitis is an infection of bone tissue that results in inflammation, vascular compromise, and progressive structural damage. Because bone is a rigid, enclosed structure with limited capacity to accommodate swelling, infection rapidly disrupts blood flow and cellular function, impairing both bone integrity and healing. In osteomyelitis, infection is difficult to eradicate, healing is prolonged, and delayed diagnosis can result in chronic disease, pathological fracture, or systemic illness.
What You Need to Know
Osteomyelitis develops when microorganisms enter bone tissue through haematogenous spread, direct inoculation following trauma or surgery, or extension from adjacent infected tissue. Once bacteria establish within bone, an intense inflammatory response is triggered. Because bone is a rigid structure with limited capacity to expand, inflammation rapidly increases intraosseous pressure, leading to oedema and compression of local blood vessels.
As perfusion declines, delivery of immune cells and antibiotics to the infected area becomes increasingly limited. Reduced blood flow also deprives bone tissue of oxygen and nutrients, impairing osteoblast function and normal bone turnover. Infection and ischaemia therefore reinforce one another, allowing bacterial persistence and progressive structural damage.
Several interrelated pathophysiological processes drive disease progression:
Inflammatory oedema increasing intraosseous pressure
Vascular compression reducing local perfusion
Impaired immune response and antibiotic penetration
Disruption of bone remodelling and repair mechanisms
Over time, ongoing inflammation and poor perfusion lead to bone necrosis and formation of devitalised segments. These changes make eradication difficult and explain why osteomyelitis often becomes chronic without timely intervention. The condition is therefore best understood as a combined infectious and ischaemic process, where compromised blood supply is as central to disease persistence as the invading microorganism itself.
Beyond the Basics
Routes of infection and initial bone seeding
Osteomyelitis develops when microorganisms gain access to bone through haematogenous spread, direct inoculation, or extension from adjacent soft tissue. The relative importance of each route varies with age and clinical context. In children, haematogenous spread is most common, with bacteria seeding the metaphyseal regions of long bones. These areas are particularly vulnerable because blood flow is slow and turbulent, allowing organisms to exit the circulation and establish infection. In adults, infection more often follows disruption of normal barriers, such as open fractures, orthopaedic surgery, penetrating trauma, or contiguous spread from chronic soft tissue infection.
Once bacteria enter bone, they adhere to the bone matrix and, when present, implant surfaces such as prosthetic material. The rigid, mineralised structure of bone limits mechanical clearance and restricts the ability of tissue to accommodate swelling. This allows infection to establish locally before significant systemic features develop. Early containment is therefore difficult, particularly in areas where vascular supply is already compromised, such as previously injured bone or tissue affected by diabetes or peripheral vascular disease.
Inflammation, pressure, and vascular compromise
Bacterial proliferation within bone triggers an inflammatory response characterised by infiltration of immune cells and accumulation of purulent exudate within the marrow cavity. Because bone is a confined space that cannot expand, this leads to a rise in intramedullary pressure (pressure within the bone marrow). As pressure increases, thin-walled venous structures are compressed first, impairing venous outflow, followed by compromise of arterial inflow.
Reduced perfusion limits oxygen and nutrient delivery, impairing cellular metabolism and promoting local tissue hypoxia. This environment reduces osteocyte viability and favours bacterial survival. At the same time, diminished blood flow restricts delivery of immune cells and antibiotics to the site of infection. This combination of hypoxia, impaired host defence, and reduced antimicrobial penetration allows infection to progress despite systemic therapy, making vascular compromise central to disease progression.
Bone necrosis and sequestrum formation
Sustained inflammation and ischaemia lead to focal loss of blood supply within the bone. When this occurs, segments of bone become devitalised and undergo necrosis. These necrotic fragments separate from surrounding viable tissue, forming sequestra (pieces of dead bone). Because sequestra are avascular, they cannot be reached effectively by immune cells or systemic antibiotics, allowing bacteria to persist within these protected niches.
In response to structural instability, surrounding viable bone attempts to compensate by forming new bone around the necrotic segment, known as involucrum. While this represents an attempt at repair and stabilisation, it often encloses and isolates the infection rather than eliminating it. As a result, the infection becomes walled off but persistent, contributing to the development of chronic osteomyelitis.
Disruption of bone remodelling and healing
Normal bone integrity depends on the balance between osteoclast-mediated resorption (breakdown of bone) and osteoblast-driven formation (new bone production). In osteomyelitis, inflammatory cytokines and bacterial factors disrupt this balance. Osteoclastic activity is increased, accelerating bone resorption, while osteoblast function is suppressed, limiting new bone formation.
This imbalance favours progressive bone loss rather than repair. In the context of fractures or orthopaedic implants, infection interferes with callus formation and structural stabilisation. This explains the increased risk of delayed union or non-union in infected bone and highlights why mechanical stability cannot be restored without controlling the underlying infection.
Acute versus chronic osteomyelitis
Acute osteomyelitis is dominated by early inflammatory changes, increased intramedullary pressure, and evolving vascular compromise. When recognised and treated promptly, these changes may be reversible, and structural damage can be limited, preserving bone viability. Clinical features are often more pronounced, reflecting active inflammation and systemic response.
Chronic osteomyelitis develops when infection persists over time, allowing necrosis, sequestrum formation, and ongoing inflammatory activity to become established. The disease often follows a relapsing course, with periods of relative quiescence interrupted by reactivation of infection. Symptoms may be less dramatic, but underlying structural damage continues to progress. Over time, this increases the risk of complications such as pathological fracture, sinus tract formation, and potential systemic spread.
Clinical Connections
Osteomyelitis commonly presents with localised bone pain, tenderness, swelling, and reduced function of the affected limb. Systemic features such as fever or malaise may be mild or absent, particularly in chronic disease, older adults, or individuals with diabetes or immunosuppression. In post-fracture or post-operative settings, pain that persists or worsens rather than gradually improving, delayed union, or unexplained functional decline should raise concern for underlying bone infection even in the absence of overt systemic illness.
Clinical presentation is shaped by the combined effects of infection and impaired perfusion. Inflammatory oedema within bone increases pressure and compromises blood flow, while necrotic bone acts as a protected reservoir for microorganisms. These mechanisms explain several common clinical patterns:
Disproportionate or persistent pain compared with expected healing
Poor response to short courses of antibiotics
Delayed fracture healing or implant failure
Recurrent or relapsing symptoms after apparent improvement
In chronic osteomyelitis, symptoms may fluctuate over time, with periods of relative stability followed by reactivation. Ongoing bone destruction can continue even when surface signs appear minimal, increasing the risk of pathological fracture and long-term functional impairment.
Management often requires more than antimicrobial therapy alone. Prolonged antibiotics are needed to suppress bacterial load, but eradication is unlikely without removal of devitalised, avascular bone and reduction of intraosseous pressure. Surgical debridement restores access for immune cells and antibiotics and supports revascularisation, which is essential for healing. Without addressing necrosis and ischaemia, infection persists and normal bone repair cannot resume.
Concept Check
Why does bone infection impair blood supply and antibiotic delivery?
How does increased intramedullary pressure contribute to bone necrosis?
Why do sequestra act as reservoirs for chronic infection?
How does osteomyelitis interfere with fracture healing and remodelling?
Why is chronic osteomyelitis difficult to eradicate completely?